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Abstract 
Patients with chronic renal failure are considered to be at risk of perioperative 
pulmonary aspiration and consequently the recommendation is to perform a rapid 
sequence induction on such patients. Rapid sequence induction is not without its 
risks and may not be necessary. 
The aim of this study was to determine whether patients who are on a chronic 
haemodialysis program have sufficient residual gastric contents after an overnight 
fast, to place them at risk of pulmonary aspiration of gastric contents during 
anaesthesia. 
The presence and volume of gastric content was ascertained by ultrasound 
examination of the stomachs of twenty patients. Patients were asked to fast 
overnight and an ultrasound was scheduled for a morning on which the patient was 
due to come in for a dialysis session. The appearance of the stomach and the 
contents were graded by the radiologist and the diameters of the gastric antrum were 
then measured so that the cross sectional area could be calculated. 
Once the cross sectional area was known the gastric volume was calculated using a 
validated equation. The risk of perioperative pulmonary aspiration was then 
assessed according to the graded appearance as well as calculated gastric volumes. 
If the stomach was found to contain fluid a cut off value of 0.8ml/kg was used as a 
relative gastric volume that would place the patient at increased risk of perioperative 
pulmonary aspiration. Any patient with a gastric antrum found to be distended with 
fluid in both the supine and lateral positions or seen to contain solid contents was 
assessed as being at increased risk of perioperative pulmonary aspiration.  
Gastrointestinal symptoms were assessed and compared to residual gastric 
volumes. Urea and creatinine concentrations were also correlated to residual gastric 
volumes.   
In this study none of the patients with chronic renal failure on a chronic 
haemodialysis program were considered to be increased risk of perioperative 
pulmonary aspiration, after an overnight fast.  
Gastrointestinal symptoms were found in 60% of patients. There was no association 
between gastrointestinal symptoms and residual gastric volumes. There was no 
correlation between either urea or creatinine levels and residual gastric volumes. 
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Chapter 1 – Overview of the Study 
 
1.1   Introduction 
In this chapter an overview of the study is given and will include: the background to 
the study, the problem statement, aim and objectives, research assumptions, 
research methodology, significance of the study, study outline and a summary. 
 
1.2   Background to the study 
Perioperative pulmonary aspiration (PPA) of gastric contents is a feared and 
potentially devastating complication in anaesthesia. The reported incidence of PPA 
varies greatly with ranges from as low as 1 in 9 229 in ASA I patients undergoing 
elective surgery to 1 in 343 in ASA IV and V patients having emergency procedures. 
Mortality after PPA was found to be 4.5% in the Mayo clinic study (1) and 3.5% in the 
AIMS study (2). PPA is presumed to be largely avoidable with proper management 
strategies and by identifying high risk groups preoperatively (3, 4). The primary 
method for reducing the risk of PPA is to ensure that the patient has an empty 
stomach prior to induction of anaesthesia. This is the basis for the preoperative 
fasting of elective surgical patients. Patients with chronic renal failure (CRF) are 
believed to have delayed gastric emptying, therefore current practice in anaesthesia 
is that such patients presenting for surgery undergo a rapid sequence induction 
(RSI), regardless of the period of preoperative fasting. In order to avoid PPA, RSI or 
modified RSI should be performed where a patient is considered to have a full 
stomach (5). 
Patients with CRF commonly present with dyspeptic symptoms such as anorexia, 
nausea, vomiting, bloating, early satiety and abdominal pain (6). There may be a 
correlation between dyspeptic symptoms and delayed gastric emptying (7). Delayed 
gastric empting secondary to autonomic neuropathy, uraemia or gastric dysmotility in 
patients with CRF can predispose them to high residual gastric volumes (RGVs) and 
consequently they are at risk of regurgitation and PPA of gastric contents. 
A number of reports evaluating gastric emptying in patients with CRF have yielded 
conflicting results. Possible reasons for this are multiple variables across the studies, 
including several different methods of assessing gastric emptying and some studies 
including patients with diabetes. There may be an association with autonomic 
neuropathy which often develops during the course of renal failure.  
A study done by McNammee (8) in 1985 showed delayed gastric emptying in 
patients with uraemia not being haemodialysed but normal gastric emptying in 
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patients receiving regular haemodialysis. In 2000 Van Vlem (6) concluded that 
patients who were receiving chronic haemodialysis and had dyspepsia had 
significantly delayed gastric emptying.  Wright (9) found in 1984 that patients with 
CRF receiving haemodialysis showed no demonstrable abnormality in gastric 
emptying whether experiencing dyspeptic symptoms or not. In 2004  Strid (10) 
demonstrated delayed gastric emptying in patients with CRF, the gastric emptying 
times were further prolonged in the patients who were on a dialysis program. He 
found no correlation between gastric emptying times and dyspeptic symptoms in 
these patients. 
The greater the volume of gastric contents the greater the risk of regurgitation and 
aspiration during anaesthesia. Once gastric contents are aspirated, subsequent 
morbidity is related to the volume of contents that are aspirated. Reference is made 
to a critical gastric volume of between 25 and 50 ml or 0.4 - 0.8 ml/kg (11, 12). 
The use of ultrasound to assess gastric volumes has been found to be highly 
reproducible and accurate (13-17). The results of a recent study concluded that 
estimation of gastric volumes by measuring cross sectional area (CSA) of the antrum 
by ultrasound could be used in clinical practice to identify the patient at risk of PPA 
during the perioperative period (18).  
Previous studies on gastric emptying in patients with CRF have focused on the 
gastric volumes for a period of up to 6 hours postprandially (8, 10, 19-21). For the 
renal patient presenting for elective surgery it is important to know if there is 
sufficient gastric volume after an overnight fast of eight hours, which would put them 
at risk of PPA of gastric contents.  
According to the reviewed literature no study could be identified that specifically 
focuses on the use of ultrasound to assess gastric volumes in patients with CRF who 
had been fasted overnight. 
 
1.3   Problem statement 
Patients with CRF are considered to be at risk of PPA and consequently the 
recommendation is to perform a RSI on such patients. RSI is not without its risks and 
may not be necessary. 
 
1.4   Aim of the study 
The aim of this study was to determine whether patients who are on a chronic 
haemodialysis program have sufficient residual gastric contents after an overnight 
fast, to place them at risk of pulmonary aspiration of gastric contents during 
anaesthesia. 
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1.5   Objectives of the study 
Objectives of the study 
The primary objective of this study was to quantify the RGVs, after an overnight fast, 
of patients who are on a haemodialysis program by means of ultrasound assessment 
of the gastric antrum. 
The secondary objectives of this study were to:  
 describe the gastrointestinal symptoms of the patients 
 compare the RGVs in patients with and without gastrointestinal symptoms 
 correlate RGVs with the urea concentrations 
 correlate RGVs with the creatinine concentrations. 
 
1.6   Research assumptions 
The following definitions were used in this study. 
Chronic haemodialysis patient: in this study refers to patients who had been on a 
haemodialysis program for a minimum of six months. The patients were dialysed 
three times weekly for a period of four hours per day. 
Dyspepsia: in this study refers to any of the following symptoms: heartburn or acid 
reflux, nausea, vomiting, abdominal bloating and early satiety. 
Residual gastric volume: in this study refers to the gastric volume in the fasted 
state. This volume will be described in mls. 
Relative gastric volume: in this study refers to the gastric volume that was 
calculated from the ultrasound measurements of the gastric antrums divided by the 
patient’s weight. This volume will be described in mls/kg. 
Qualitative assessment: The sonographic appearance of the gastric antrum made 
using a three point grading system (22): 
 Grade 0: The antrum is assumed to be empty. The anterior and posterior 
walls are adjacent to one another and no fluid can be visualised in either the 
supine or the lateral decubitus position. 
 Grade 1: The antrum is assumed to contain a volume of fluid within the “safe” 
range (less than 0.8ml/kg). The fluid can only be visualized in the lateral 
decubitus position and not in the supine position. 
 Grade 2: These patients may be considered at risk of perioperative 
pulmonary aspiration (volume greater than 0.8ml/kg). The gastric antrum is 
distended in both the supine and the lateral positions. If the distended lumen 
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is hypoechoic it contains fluid. If it has a frosted glass appearance it contains 
solid contents. 
 
Empty Stomach: 
 volume of gastric contents not exceeding 0.4 ml/kg body weight, or 
 Grade 0 appearance on ultrasound 
Not at increased risk of PPA: 
 volume of gastric contents greater than 0.4 ml/kg but less than 0.8 ml/kg and 
 Grade 1 appearance on ultrasound. 
At risk of PPA: 
 gastric contents which exceed 0.8 ml/kg, or 
 Grade 2 appearance on ultrasound 
 
1.7   Research methodology 
1.7.1 Research design 
A prospective, cross sectional, descriptive research design was used. 
1.7.2 Study population 
The study population comprised patients who were treated in a haemodialysis unit in 
a private hospital in Johannesburg. 
1.7.3 Study sample 
A convenience sample was used in this study. The sample size was realised by the 
number of patients that met the criteria for this study. 
Inclusion and exclusion criteria 
The following inclusion criteria were used in the study: 
 patients with CRF who were 18 years or older 
 patients who had been on haemodialysis for at least six months, and 
 patients who consented to take part in the study. 
Patients with the following were excluded from the study: 
 diabetes mellitus 
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 a history of previous surgery which could distort the anatomy of the stomach 
and oesophagus 
 a history of hiatus hernia 
 those patients on medications which may affect gastric emptying such as 
erythromycin or metoclopramide 
 a BMI> 35 kg/m2 
 patients who were pregnant. 
 
1.7.4 Data collection 
All patients attending the dialysis unit who met inclusion criteria were identified. They 
were then approached, the study was explained to them by the researcher and an 
information sheet detailing the study was provided to them. If they agreed to 
participate they were asked to sign consent. They were then asked about 
gastrointestinal symptoms, and blood results for urea and creatinine concentrations 
were taken from their files. 
An ultrasound was scheduled for a morning on which the patient was due to come in 
for a dialysis session. The patient was asked to take nothing by mouth from bedtime 
or midnight from the night before the ultrasound.  
The appearance of the stomach contents was assessed visually on ultrasound by 
the radiologist and the area of the gastric antrum was measured so that gastric 
volumes could be calculated. Once the ultrasounds were completed patients 
proceeded to the dialysis unit where they received breakfast and their haemodialysis 
was commenced. 
1.7.5 Statistical analysis 
Raw data was captured using Excel 2013 (Microsoft USA). Data was analysed using 
StatCalc version 7.3.3, a program by AcaStat software. A Fisher’s exact test was 
performed to check for any association between presence of gastrointestinal 
symptoms and gastric volumes which were divided into those above 0.4 ml/kg and 
those below. Continuous variables such as plasma concentrations of urea and 
creatinine, as well as gastric volumes, were compared using Pearson correlation 
coefficient. 
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1.8  Significance of the study 
This study may help identify whether the patient who has CRF and is being treated 
with haemodialysis is at risk of PPA after an overnight fast. If these patients are 
found to have raised residual gastric content then measures to minimize the risks of 
PPA need to be taken. This may reinforce current practice. If however the findings 
are that such patients have insignificant residual gastric contents then these 
measures may not be necessary. One of the measures taken to reduce the risk of 
PPA is the performance of RSI. There are risks associated with the performance of 
RSI, amongst which are haemodynamic instability, airway damage, hypoxia and 
failed intubation (23, 24). 
 
1.9 Study report outline  
The outline of the study report is as follows. 
 Chapter 1: Overview of the study 
 Chapter 2: Literature review 
 Chapter 3: Research methodology 
 Chapter 4: Results and discussion 
 Chapter 5: Summary, limitations, recommendations and conclusions. 
 
1.10 Summary 
This chapter provided an overview of this study. It included the background to the 
study, the problem statement, aim and objectives, research assumptions, research 
methodology, significance of the study, and study outline. 
In the next chapter a review of the relevant literature is presented. 
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Chapter 2 – Literature review 
 
2.1   Introduction 
Patients presenting for surgery are divided by the anaesthetist into two groups. The 
first group comprises those patients with potentially ‘full stomachs’, which means that 
they are at risk of PPA. The second group of patients are those who are fasted with 
no reason to expect delayed gastric emptying; these patients are not considered to 
be at risk of PPA. These two groups of patients are managed differently. Currently 
patients with CRF are put into the first group. There have been many studies done to 
measure gastric emptying in patients with CRF and there is currently no clear 
consensus between studies. The literature will be reviewed with regard to the normal 
physiology of gastric emptying, methods of assessing gastric emptying, CRF, 
dialysis and PPA. 
 
2.2   Physiology of gastric motility and emptying 
Gastric motility is controlled by an intrinsic and an extrinsic nervous system as well 
as by numerous hormones and neurotransmitters. Gastric emptying is the process of 
transferring food from the stomach to the duodenum. When food enters the stomach, 
the fundus and upper portion of the body of the stomach relax to accommodate the 
food; this is known as receptive relaxation. Peristalsis begins and the food is mixed 
with acid, mucus and pepsin. The chyme produced is then passed through the 
pylorus to the duodenum. Gastric emptying is promoted by intense peristaltic 
contractions, which generates pressure in the antrum, and is opposed by tonic 
contractions of the pyloric sphincter, which creates resistance to emptying of gastric 
contents. Liquids empty much faster than solids. Pyloric sphincter tone is under the 
control of the nervous system as well as humoral signals. (25) 
2.2.1 Neural control of gastric motility 
The intrinsic nervous system, which lies in the wall of the gut, is known as the enteric 
nervous system. It is composed of two plexuses, the myenteric plexus and the 
submucosal plexus. The myenteric plexus controls the motility of the gastrointestinal 
system. The submucosal plexus controls the local blood flow and gastrointestinal 
secretion of various enzymes, hydrochloric acid and mucus. The enteric nervous 
system is stimulated by stretch receptors in the stomach in response to food, which 
increases gastric motility as well as increasing pyloric tone, thus preventing 
emptying. The enteric nerve endings secrete many neurotransmitter substances 
including acetylcholine, noradrenalin, serotonin, cholecystokinin (CCK), vasoactive 
intestinal polypeptide, somatostatin and substance P. Noradrenalin inhibits 
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gastrointestinal activity and acetylcholine stimulates it. There is still uncertainty about 
the major functions of most of the other gastrointestinal neurotransmitters. (25) 
The gastrointestinal system is also controlled by the autonomic, or extrinsic system. 
Sympathetic and parasympathetic nerve fibres connect with the enteric nervous 
system and can further activate or inhibit gastrointestinal functions. Parasympathetic 
impulses are transmitted via the vagus nerve. Activation of the parasympathetic 
system stimulates the enteric system which causes a general increase in 
gastrointestinal activity. Injury to the vagus nerve will impair gastric emptying (26). 
Vagal activity results in increased gastrin secretion, as well as decreased 
somatostatin secretion (27).  
Sympathetic activation inhibits gastrointestinal functions by release of noradrenalin, 
which inhibits smooth muscle. Sensory neurons in the gut wall send afferent 
impulses back to the myenteric and submucosal plexuses as well as to the 
sympathetic nervous system and the brain stem via the vagus nerve. Afferent 
parasympathetic innervation from the vagus nerve regulates receptive relaxation, 
antral contractions and pyloric relaxation (28). 
The presence of food in the duodenum acts to inhibit gastric emptying through 
inhibitory nervous reflexes via the enteric nervous system as well as the extrinsic 
nervous system. Gastric contractions are slowed and pyloric tone is increased. (25) 
2.2.2 Hormonal control of gastric motility and emptying 
Inhibition of gastric motility and emptying is largely due to duodenal factors. 
Distention of the duodenum, high acidity and fat content in the duodenum, and 
irritation of the duodenum all prevent further gastric emptying, thus preventing the 
small intestine from becoming overwhelmed by a sudden influx of food. Hormones 
responsible for this inhibition include CCK, secretin and gastric inhibitory peptide. 
(25) The presence of food in the duodenum acts to slow gastric emptying by 
inhibitory feedback mechanisms involving gastrointestinal hormones as well as 
nervous reflexes. CCK is released by cells in the duodenum and is then carried in 
the blood back to the stomach where it acts to inhibit the action of increased motility 
produced by gastrin, hence decreasing gastric emptying. (27) CCK also increases 
the contractile function of the pyloric sphincter, blocking the passage of food from the 
stomach to the duodenum (26). Gastric inhibitory polypeptide is secreted by the 
mucosa of the small intestine in response to fatty acids, amino acids and 
carbohydrates. Secretin which is secreted in response to increased acidity in the 
gastric contents has a direct inhibitory effect on the gastric smooth muscle. (25, 27)  
Gastric emptying is promoted by the presence of food in the stomach and stretching 
of the stomach wall. Hormones involved include gastrin which is released from the 
gastric mucosa in response to the presence of food in the stomach. It is released 
directly by neural stimulation by the vagus nerve (27). The effects are release of 
gastric hydrochloric acid as well as increased motility and promotion of gastric 
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emptying (25). Nitric oxide mediates pyloric relaxation as a result of interactions with 
both intrinsic and vagal pathways and thus facilitates passage of gastric contents 
into the duodenum. (26) 
 
2.3   Methods of assessing gastric emptying  
There are many techniques for assessing gastric emptying; all have their advantages 
and disadvantages. As ultrasound is the method chosen for this study it will be 
discussed in greater detail. 
2.3.1 Ultrasound 
Ultrasound has numerous advantages over the other commonly used techniques for 
assessment of gastric volumes and emptying, amongst which are portability, non-
invasiveness and cost effectiveness (22). Numerous studies have confirmed 
ultrasound as a valid method of assessing both gastric content and gastric emptying 
(13, 14, 16, 18, 29, 30). This method has also been found to be highly reproducible 
with inter observer measurement error of 0.3% (31). According to calculations 
performed by Bouvet et al, (18) measurements of the CSA of the gastric antrum are 
sensitive enough to detect the presence of fluid volumes of as little as 25ml. 
In 2009 in Toronto, Perlas et al (15) evaluated the feasibility of bedside ultrasound to 
assess gastric content and volume. Eighteen volunteers were assessed by means of 
ultrasound in the fasting state as well as after ingestion of 250mls of water, 500mls 
of water, 500mls of effervescent water and a solid meal. A complete cross sectional 
view of the antrum was obtained 100% of the time at baseline and after fluid intake, 
but it was only visualized 72% of the time after a solid meal. The antral CSA 
increased proportionally to the intragastric fluid volumes within the range studied. 
The gastric antrum also had a distinct sonographic appearance when empty, after 
fluid intake, effervescent water and after a solid meal. 
In 2011 Perlas et al (22) did a prospective descriptive study on the use of ultrasound 
as a diagnostic tool to assess gastric volumes in 200 adult, fasted, surgical patients. 
A three point grading system was proposed based on qualitative sonographic 
appearance of the gastric antrum. In this grading system Grade 0 corresponded to a 
completely empty stomach. Grade 1 corresponded to negligible fluid volumes (16 ± 
36ml) which are within the normal ranges expected for fasted surgical patients. 
Grade 2 corresponded to significantly higher gastric volumes (180 ± 83ml) which 
would place the patient at risk of PPA. (22) 
In 2013 Perlas et al (17) proposed a new mathematical model to assess gastric 
volumes using bedside ultrasound. In this study 108 fasted patients were 
randomised to receive 6 different quantities of apple juice ranging from nothing to 
400mls. An ultrasound was performed prior to drinking the juice to confirm that the 
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stomachs were empty. After consumption of the apple juice another ultrasound was 
performed and the sonographer graded the stomach and the CSA was determined. 
The patients then underwent light sedation and upper gastrointestinal endoscopy 
was performed with observed volumes suctioned under direct vision. The study 
confirmed accuracy of the grading system by the sonographer as well as the model 
proposed for determination of the gastric volumes. Volume = 27 + 14.6 × right lateral 
CSA - 1.28 × age. 
In 2014 a review article on the use of ultrasound to assess gastric content and 
volume was published which proposed an algorithm for the use of ultrasound in 
clinical practice (30). The suggestion according to the algorithm is that first a 
qualitative assessment of the gastric antrum is performed by scanning the patient in 
the supine and right lateral decubitus position. If the stomach is found to be empty 
(Grade 0) there is low aspiration risk and no further action is necessary. If there is 
fluid seen then the volume of fluid is calculated using the mathematical model 
proposed by Perlas in the equation above. Any solid content seen automatically 
places the patient at high risk for aspiration. 
Ultrasonography offers an imaging technique which measures the rate and pattern of 
gastric emptying (32). The use of ultrasound is particularly useful to the anaesthetist 
in assessing gastric content and volume preoperatively so as to identify those 
patients at risk of PPA. Bouvet et al did a study in 2011, in France, of 183 patients. In 
this study a preoperative ultrasound measurement of the antral CSA was performed 
for each patient and then gastric contents were aspirated after tracheal intubation. 
The relationship between the measured antral area and the volumes aspirated were 
then analysed. Ultrasonographic measurement of antral CSA increased in proportion 
to the aspirated volume of gastric contents (18). 
A study by Koenig et al in 2011 aimed to detect gastric contents by means of 
ultrasound prior to emergency endotracheal intubation. Ultrasound was performed 
on 80 patients presenting for emergency intubation in order to assess gastric fluid 
content. Fluid was identified in 24% of patients and in 16% there was sufficient 
content to necessitate insertion of a gastric tube to evacuate the stomach. Repeat 
ultrasound preformed after removal of the gastric contents confirmed the absence of 
fluid in the stomach. The performance of the ultrasound took less than two minutes. 
(33) 
There are some limitations to the use of ultrasound for assessment of gastric 
volumes. It is operator dependent and there is the need for an appropriate soft tissue 
window and therefore there may be limitations in obese patients. Very large volumes 
in the antrum may not be fully visualized. A significant amount of air in the antrum 
may also invalidate the results. (15, 22) 
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2.3.2 MRI 
Through multiple transaxial abdominal scans, 3D images of the stomach and any 
contents within can be constructed. Single shot images can also give a 
measurement of the gastric contents at a specific point in time. This method is 
however limited by the cost, specialized equipment and supine position that the 
patient would have to maintain during the study. (32, 34) 
2.3.3 Gamma Scintigraphy 
Considered the gold standard of gastric emptying studies (32), this method of 
assessing gastric emptying involves ingestion of a radiolabeled meal. The 
radioactivity in the stomach is then measured at successive intervals and is directly 
proportional to the volume of meal remaining in the stomach. It is widely available, 
validated and reproducible. Unfortunately there is a small amount of radiation 
exposure and a lack of uniform methodology across centres. (34)  
2.3.4 Breath tests 
This technique involves using 14(C) octanoic acid as a marker to assess solid gastric 
emptying. There is no radiation exposure, the test is simple and does not require 
special equipment on site and can be done at the office or at home (34). It was 
concluded in a study that compared breath tests to gamma scintigraphy that the 
breath test is a reliable non-invasive test to assess gastric emptying rates of solids 
(35). Octanoic acid dissolves in and is bound to egg when baked. After ingestion it is 
broken down by pancreatic enzymes in the duodenum. 14(C) Octanoic acid is 
absorbed and transported to the liver where it is preferentially oxidized to 14CO2 (32). 
There are limitations to the use of breath tests in renal failure and particularly in 
patients who are on haemodialysis (36). 
2.3.5 Nasogastric aspiration of gastric contents 
Although previously widely used this technique has been largely abandoned in 
clinical practice due to its invasive nature. The other disadvantage of this method of 
assessing gastric contents is that it only measures liquid contents and thus is not an 
accurate reflection of solid contents (32). 
 
2.4   Chronic Renal Failure  
The kidneys are responsible for filtering toxins, adjusting body fluid composition, 
electrolyte homeostasis and acid-base balance. They are also responsible for many 
neurohumoral and hormonal functions. CRF results in progressive decline in the 
glomerular filtration rate (GFR) with accumulation of toxins and blood nitrogenous 
wastes, mainly urea. Fluid and electrolytes are also retained as urine production 
diminishes. End stage renal disease (ESRD) occurs when there is a complete or 
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almost complete failure of the kidneys to function. Clinical evidence of uraemia 
occurs when the GFR falls below 15ml/min (37). 
2.4.1 Pathophysiology of gastric emptying in CRF 
Gastroparesis is a chronic motility disorder of the stomach which involves delayed 
emptying of both liquids and solids, without evidence of mechanical obstruction (38). 
It is generally believed that gastroparesis involves abnormalities at three levels: the 
autonomic nervous system, the enteric neurons and the smooth muscle (39). 
In the patient with CRF there are multiple potential mechanisms for delayed gastric 
emptying amongst which are gastric mucosal oedema, electrolyte disturbances, 
chronic uraemic toxicity, autonomic neuropathy and altered gastrointestinal peptide 
levels (40, 41). 
Autonomic involvement is common in metabolic disorders characterized by small-
fiber damage, such as ESRD. The pathophysiology of the axonal damage is 
probably due to the action of as yet unknown uraemic toxins to nerve fiber (42).  
In 1995 Dumitrascu et al (19) studied 15 patients with CRF. The gastric antrum was 
assessed by means of ultrasound. Autonomic dysfunction was assessed clinically. 
The subgroup of patients with both sympathetic and parasympathetic dysfunction 
had delayed gastric emptying. Patients with only parasympathetic dysfunction had 
normal gastric emptying and patients without autonomic dysfunction had accelerated 
gastric emptying. 
Gastrointestinal hormones are secreted by the cells in the gastrointestinal system. 
These hormones are inactivated and cleared by the kidneys and it has been found 
that their levels increase significantly as a consequence of uraemia (43-45). Serum 
levels of several polypeptide hormones involved in the modulation of gastrointestinal 
motility (e.g. gastrin, CCK, neurotensin) are significantly raised as a consequence of 
renal insufficiency. Furthermore, several other electrolyte abnormalities such as 
hypercalcaemia and hyperkalaemia are common in CRF, as are acid base 
disturbances. These abnormalities may play an important role in gastrointestinal 
dysmotility observed in CRF by directly affecting the smooth muscle of the gut or 
stimulating particular areas within the central nervous system (46). 
Standard teaching is that there is delayed gastric emptying in chronic uraemia (5). 
The concept of delayed gastric emptying is critically important to the anaesthetist. 
Delays in gastric emptying result in stasis of gastric contents and consequently risks 
of regurgitation, vomiting and pulmonary aspiration of gastric contents during 
anaesthesia.  
Multiple studies on gastric emptying in CRF have yielded conflicting results. Some of 
the studies have small sample sizes, and some include patients with diabetes, who 
are known to have delayed gastric emptying (47). Another possible explanation for 
the differing results are the different methods of assessing gastric emptying. Other 
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areas of debate are the effects of haemodialysis on gastric emptying and the 
possible relationship between dyspepsia and gastric emptying. 
In 1984 Wright et al (9) performed a radionucleotide study of gastric emptying times 
in a group of 20 haemodialysis patients. Ten of the patients had symptoms of 
nausea and vomiting and the other ten did not. No abnormality in gastric emptying 
was found in any of the patients. Soffer et al (20) did a study in 1987 in Israel in 
which 18 patients who were controlled with haemodialysis were assessed for 
delayed gastric emptying. Nine of these patients described nausea, vomiting and 
postprandial bloating. The 18 patients were compared to a control group of healthy 
subjects. A radionucleotide method was used and retention of isotope after two and 
a half hours was assessed. No delayed gastric emptying was found in any of the 
patients. 
In 1985 McNammee et al (8) studied 14 patients with CRF, using a radionucleotide 
technique to assess gastric emptying. The group was split into four patients who had 
been receiving regular haemodialysis for six to twelve months, and ten patients who 
had not yet been haemodialysed. No reference was made as to the diabetic status of 
any of the patients. Eleven healthy volunteers were used as control subjects. The 
results showed a significant retention of isotope in the stomachs of the patients not 
receiving haemodialysis as compared to the control subjects, with a p < 0.05 at 90 
minutes. Three of the four patients on haemodialysis had normal gastric emptying 
although no comment was made as to the degree of the delay in gastric emptying in 
the fourth patient.    
In 1996 Kao et al (21) used a radionucleotide technique to assess gastric emptying 
in Chinese patients with CRF. There was a sample size of 40 patients in this study. 
Diabetic patients were excluded from the trial as were any patients who had peptic 
ulcer disease, previous abdominal surgery or any other factor which could influence 
gastric emptying. Twenty of the patients were receiving regular haemodialysis and 
the other 20 were not yet receiving haemodialysis. There was a control group of 25 
healthy volunteers. Of the 40 patients, 35 patients (88%) had delayed gastric 
emptying as defined by two standard deviations above the mean of the control 
group. There was no statistical difference in gastric emptying in the patients 
receiving haemodialysis. Thus it was concluded that there is a high incidence of 
delayed gastric emptying in the Chinese population with CRF whether they are 
dialysed or not. (21) 
A more recent study by Strid et al (10) in 2004 in Sweden assessed gastric emptying 
in 39 patients with CRF. Gastric emptying was assessed by radionucleotide method. 
The gastric emptying results were compared to reference values previously obtained 
from 131 healthy control subjects. Seventeen of the patients were receiving 
haemodialysis, 9 were on peritoneal dialysis and 13 patients were not yet on dialysis. 
No diabetic patients were included. Eighteen of the patients had gastrointestinal 
symptoms. Delayed gastric emptying was found in 14 (36%) of the patients. There 
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was delayed gastric emptying in six of the 17 patients on HD (35%), six of the nine 
patients on PD (66%) and only two of the 13 predialysis patients (15%). The degree 
of uraemia in the predialysis patients was not discussed, nor was the duration of the 
CRF. There was no association between delayed gastric emptying and 
gastrointestinal symptoms.  
In 2001, in Belgium, De Schoenmakere et al (48) studied gastric emptying in 56 
haemodialysis patients which were compared to a healthy control group.  Gastric 
emptying was assessed using radionucleotide evaluation. Gastric emptying was also 
compared to biochemical indicators of nutritional status and the conduction velocity 
of the fibular nerve. Results showed significant delays in gastric emptying (p<0.05) in 
the CRF group compared with the control group. In 20 patients gastric emptying time 
was more than double that of the control group. Further findings were that the 
patients with the greatest delays in gastric emptying had lower prealbumin levels and 
mean fibular nerve conduction velocity was slower (p<0.05) than those patients with 
normal gastric emptying. As prealbumin is considered an indicator of nutritional 
status the authors concluded that delayed gastric emptying in end stage renal failure 
could lead to malnutrition. 
2.4.2 Gastric Motility in chronic renal failure 
Gastric myoelectrical activity is a non-invasive method of assessing the motility of 
the gastrum of the stomach using surface electrodes on the abdomen which record 
an electrogastrogram (EGG). An abnormal EGG may predict delayed gastric 
emptying (49). Patients with CRF are found to have abnormal gastric myoelectrical 
activity. (50, 51) 
In a study done in 2005 by Hirako (52) in Japan, gastric motility was assessed by 
means of an EGG. The aim of this study was to try and correlate a relationship 
between gastric motility, gastric emptying and gastrointestinal symptoms. Gastric 
emptying was assessed by means of a 14(C) octanoic acid breath test. There were 
21 patients included in the study who were matched with 21 healthy controls. 
Diabetic patients were not excluded. All of the patients had end stage renal failure 
but were not yet on haemodialysis. The patients with CRF had a higher percentage 
of fasting bradygastria compared to controls in the fasting state (P<0.05) and the 
postprandial state (p<0.01). Gastric emptying time was significantly slower in the 
group of patients with CRF compared with the controls (p<0.01). The study 
confirmed a high percentage of patients with both abnormal gastric motility and 
delayed gastric emptying which correlated with an increased incidence of 
gastrointestinal symptoms (p<0.05). (52) 
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2.4.3 Effect of dialysis on gastric emptying 
Dialysis therapy is known to remove uraemic toxins and prevent or delay uraemic 
complications.  
In a study by Ko et al  (53) in Taiwan aimed at ascertaining whether haemodialysis 
alters gastric myoelectrical activity, 21 uraemic patients on haemodialysis with 
dyspeptic complaints were studied. Diabetic patients were excluded. Myoelectric 
activity was assessed using EGG as previously described. The patients were split 
into two subgroups: a chronic dialysis group comprised seven patients who had been 
on dialysis for more than five years and a new dialysis group comprised fourteen 
patients who had been on dialysis for less than a month. They found a low 
percentage of normal waves in all the patients both before and after dialysis 
(p<0.01), confirming abnormal myoelectrical activity in uraemia. However they found 
that there was a higher percentage of bradygastria (p < 0.05), in both the fasting and 
fed state, in the patients immediately after haemodialysis compared to before 
dialysis, concluding that haemodialysis itself compromises gastric myoelectrical 
activity in the period directly after dialysis. However haemodialysis was found to 
have no long term effect on gastric motility. (53) It is suggested that dialysis-
associated hypotension causing periods of poor perfusion to the stomach may be a 
reason for the reversible gastric dysrhythmia noted (54). 
Haemodialysis does not appear to remove the circulating gastrointestinal hormones 
involved in gastric emptying. In 1984 Sirinek et al (44) studied a group of 15 patients 
with CRF requiring haemodialysis. “Blood samples before and after 4 hours of 
haemodialysis were assayed for creatinine, blood urea nitrogen, potassium, calcium, 
glucose, insulin, gastrin, gastric inhibitory polypeptide, vasoactive intestinal 
polypeptide, pancreatic polypeptide, somatostatin, motilin, and neurotensin levels. 
Before dialysis, serum gastrin was minimally increased whereas gastric inhibitory 
polypeptide and pancreatic polypeptide were grossly increased compared with 
normal fasting values. Haemodialysis produced no changes in serum gastric 
inhibitory polypeptide, vasoactive intestinal polypeptide, pancreatic polypeptide, 
somatostatin, motilin, and neurotensin. Slight increases in serum insulin and gastrin 
levels may have occurred secondary to a dialysis-induced increase in the serum 
calcium level. The kidneys appear to be a major site of inactivation of insulin, gastrin, 
gastric inhibitory polypeptide, and pancreatic polypeptide. Dialysis does not seem to 
remove these hormones. Gastrin levels, although elevated in renal failure, may be 
suppressed by very high circulating levels of gastric inhibitory polypeptide.” (44) 
A study in 2007 in Japan by Adachi (55) found improvement in the gastric emptying 
times and gastric motility in patients being dialysed compared with those who were 
predialysis. 
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2.4.4 Dyspepsia and gastric emptying 
Renal patients often have dyspeptic symptoms. Common complaints include 
nausea, vomiting, postprandial bloating, early satiety, and anorexia. These dyspeptic 
complaints have formed the basis for many of the studies on gastric emptying that 
have been done on patients with CRF. 
In 2000 Van Vlem et al (6) did a study in Belgium on 54 patients with CRF who were 
receiving chronic haemodialysis. The aim of the study was to determine whether 
delayed gastric emptying was related to dyspeptic symptoms. Seventeen patients 
(31%) were graded as dyspeptic, using specific symptoms such as nausea, vomiting, 
abdominal distension and early satiety. Gastric emptying was assessed by means of 
the 14(C) octanoic acid breath test. There was a significant delay in the gastric 
emptying times in the haemodialysis patients compared with the healthy controls 
(p<0.01) as well as in the dyspeptic haemodialysis patients compared with the 
nondyspeptic haemodialysis patients (P<0.01). The effect of haemodialysis on 
gastric emptying times was also assessed by checking gastric emptying times before 
and after a dialysis session, and although the gastric emptying times were slightly 
longer after dialysis it was not statistically significant. Gastric hypomotility with 
associated delays in gastric emptying  appear to contribute significantly to the 
generation of dyspepsia in patients with CRF (52). 
 
2.5   Pulmonary aspiration 
Pulmonary aspiration is a well-recognized complication in anaesthesia. In a 
landmark study in 1946, Mendelson (56) described pulmonary aspiration among 
obstetric patients, with significant morbidity and mortality. Certain high risk groups of 
patients, such as the obstetric patient, the patient with hiatus hernia, the patient with 
bowel obstruction or the trauma patient have since been identified. Patients with 
large gastric volumes are at risk of regurgitation and aspiration of gastric contents 
during anaesthesia and as such the concept of the preoperative fast came about. 
Included in the traditionally accepted groups of patients at high risk of PPA are those 
with CRF. 
According to Miller’s Anesthesia; “all patients presenting for kidney transplantation 
should be considered to have full stomachs, regardless of the period of preoperative 
fasting.” Patients with uraemia and other comorbid conditions (e.g., diabetes) should 
be considered at risk of aspiration during induction of anaesthesia. To prevent reflux 
and aspiration, RSI while maintaining cricoid pressure should be considered (5). 
PPA involves the inhalation of oropharyngeal or gastric contents into the respiratory 
tract. These aspirations may include large food fragments which can occlude the 
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airway and lead to rapid asphyxiation, smaller particles which can produce a severe 
granulomatous inflammation, gastric acid which can induce a chemical pneumonitis 
and faeculent material which can cause an infectious pneumonia. (57)  
Once pulmonary aspiration has occurred the consequences can vary from benign to 
lethal. Studies have found that in the majority of aspirations no complications 
resulted (2, 3, 58, 59).  However, where patients developed signs of aspiration 
(crepitations, wheezing, hypoxemia, tachycardia, dyspnoea and infiltrates on chest 
X-ray) within two hours of the aspiration, the majority then required respiratory 
support and intensive care management (1). The mortality rates after aspiration as 
seen in the Mayo clinic study (1) and the AIMS study (2) approximates one in 20 
patients.  
The Mayo clinic study evaluated patients over a six year period from 1985 through to 
1991. A total of 215 488 patients were reviewed. PPA occurred in 67 patients 
(1:3216). The rate for emergency surgery was 1:895 and for elective surgery was 
1:3886. Sixty-six of the patients survived the surgery. Of these, 42 had no sequelae, 
24 had signs and symptoms of aspiration within two hours and 13 required 
mechanical ventilation, 6 of whom required ventilation for greater than 24 hours. 
Three of these patients died. The total mortality was 1 in 22. (1) 
The AIMS study done in New Zealand by Kluger and Short (2) reviewed 133 cases 
of reported PPA in which five patients died. All of these patients however were 
believed to have significant co-morbidities. In a computer aided study of the 
incidence of PPA in 185 358 anaesthetics 83 cases of aspiration were retrieved. In 
83% of these cases there was a preoperative factor which indicated an increased 
risk of aspiration, with 61% having a history suggestive of delayed gastric emptying 
(peptic ulcer, pregnancy, obesity, stress, pain, increased intracranial pressure). (60) 
In another retrospective study on the incidence and outcome of PPA done in 
Pennsylvania in 2006 by Sakai et al, the incidence of PPA was found to be low 
(1:7103) and of mortality especially low (1:99 441). Seventy percent of the incidents 
were associated with anaesthetic management that could have been improved, 
which suggests that in the majority of cases PPA can be prevented (3).  
2.5.1 Risk factors for pulmonary aspiration 
Multiple factors have been identified which place the patient at increased risk of 
PPA, specifically increased volume of gastric contents for whatever reason. Studies 
of PPA have found that in most cases a risk factor had been identified 
preoperatively. (3, 59)  
Gastrointestinal obstruction is the factor most often associated with PPA (57). 
Emergency surgery, extremes of age, patients with severe pain, obstetric patients 
and patients with impaired gastric emptying or a history of gastroesophageal reflux 
would be considered at increased risk of PPA. Difficult intubation, especially with 
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inadequate muscle relaxation is another risk factor (11). A study by Olsson in 1986 
found a six fold increased incidence of PPA at night compared to the day, perhaps 
due to greater number of emergency cases and a less experienced team (60). 
Once rendered unconscious under general anaesthesia protective airway reflexes 
are lost, lower oesophageal sphincter tone is reduced and passive regurgitation of 
gastric contents can occur (11). Passive regurgitation is promoted by increased 
intragastric volume or pressure. The nature of the gastric contents aspirated may 
have further consequences in terms of the severity of subsequent lung damage. (4, 
57) 
A critical volume which when aspirated produces aspiration pneumonitis of 0.4ml/kg 
or 25 ml has been quoted (61). However there is evidence to suggest that volumes 
of up to 0.8ml/kg are well tolerated (12). Volumes of up to 1.5 ml/kg have been 
considered safe (30). 
2.5.2 Prevention of pulmonary aspiration  
Preoperative fasting  
According to the ASA task force report on preoperative fasting guidelines (62) a 
preoperative interview should include pertinent assessment of gastrointestinal 
symptoms such as reflux, dysphagia and motility disorders. The potential for difficult 
airway management should be assessed. A history of any metabolic disorders which 
may place the patient at increased risk of regurgitation and pulmonary aspiration, 
should also be taken. 
Minimum fasting periods are two hours for clear liquids, four hours for breast milk, six 
hours for formula milk, cow’s milk and a light meal (such as toast and liquids) and 
eight hours for a meal containing fried or fatty foods (62). 
Rapid sequence induction 
Patients who are deemed to be at high risk of pulmonary aspiration of gastric 
contents during general anaesthesia should have their airways secured with an 
endotracheal tube. Furthermore the use of a RSI is recommended (11). The primary 
goal of RSI is to minimize the time between loss of consciousness and tracheal 
intubation (23), thus minimizing the risk of PPA. RSI requires good preparation. 
Adequate intravenous access should be established and the patient should be 
monitored. The technique includes preoxygenation, rapid administration of a 
predetermined dose of induction agent and paralytic drug, concurrent use of cricoid 
pressure, avoidance of bag mask ventilation, direct laryngoscopy and endotracheal 
intubation. (11, 24) 
The use of RSI should however be reserved for those patients where the risk of 
aspiration outweighs the potential risks associated with RSI. The most frightening of 
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these is the possible inability to secure the airway or ventilate the patient leading to 
hypoxia, hypercarbia and airway trauma (23). 
RSI involves the rapid administration of a predetermined dose of an induction agent. 
This may result in drug over or under-dosing, precipitating severe haemodynamic 
changes (24). The patient with renal failure often has multiple co-morbidities such as 
cardiomyopathy, hypertension, ischaemic heart disease, central nervous system 
disturbances and anaemia. Sudden hemodynamic changes, such as tachycardia, 
hypotension and hypertension can result in serious morbidity, including myocardial 
ischemia, strokes and renal hypo-perfusion further compromising renal function. (5) 
Succinylcholine is traditionally considered the muscle relaxant of choice for RSI due 
to its fast onset, providing excellent intubating conditions, and its short duration of 
action (63). There are however potential adverse effects associated with the 
administration of succinylcholine. Its use is contraindicated, due to the possibility of 
life threatening hyperkalaemia, in certain situations, such as CRF associated with a 
raised serum potassium, spinal cord injury and in patients with burns (23). It is a 
potential trigger for malignant hyperthermia, it can cause increases in intracranial 
and intraocular pressure, it can cause bradycardias, particularly in children or with 
repeated doses and the fasciculations can cause postoperative myalgia.   
In situations where succinylcholine is contraindicated a non-depolarizing muscle 
relaxant such as rocuronium can be used. The onset of action can equate to 
succinylcholine but only if a larger dose is used, resulting in a much longer duration 
of action. If there are difficulties intubating and ventilating the patient the effects 
could be disastrous. Rocuronium would also not be the muscle relaxant of choice in 
a patient with CRF due to its renal excretion. 
The use of an endotracheal tube is also not without its risks. Although providing a 
secure airway, thus minimizing the risk of aspiration and allowing for controlled 
ventilation, there are numerous potential complications. There can be complications 
from the laryngoscope blade itself, which may cause trauma to the teeth, lips, tongue 
or pharynx. Largyngoscopy if not performed under a sufficiently deep level of 
anaesthesia may induce a sympathetic response, resulting in tachycardia and 
hypertension which is especially undesirable in patients at risk of myocardial 
ischemia, such as those with CRF. It may also trigger laryngospasm or 
bronchospasm in susceptible individuals. The tube itself can cause trauma to the 
airway and vocal cords or may be misplaced either into the oesophagus or 
endobronchially. (64) 
Gastric stimulants 
The routine preoperative use of gastrointestinal stimulants such as metoclopramide, 
which accelerates gastric emptying, to decrease the risk of PPA in patients who have 
no apparent increased risk for PPA is not recommended (62).  However in cases 
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where there is a known risk for PPA, such as in pregnancy, these agents are 
routinely used often in combination with an agent to raise the gastric pH. (58) 
 
2.5.3  Pharmacological agents used to attenuate risks of PPA 
Pharmacological blockade of gastric acid secretion 
Proton pump inhibitors and histamine-2 receptor antagonists decrease the acidity of 
gastric contents. They may be useful in a high risk patient with history of reflux or 
PUD; however ASA guidelines do not support their routine use in patients who are 
not considered to be at risk of PPA (62). 
Preoperative antacids 
The literature does not show any relationship between reduced gastric acidity and 
volume secondary to the use of these drugs and improved clinical outcome (62). 
The routine preoperative use of antacids to decrease the risk of PPA in patients who 
are not at increased risk for PPA is not recommended (62). 
 
2.6  Summary 
This chapter described the physiology of gastric motility and emptying, methods of 
assessing gastric emptying, the impact of CRF on gastric emptying, the effects of 
dialysis on gastric emptying and the relationship between dyspepsia and gastric 
emptying. Pulmonary aspiration was also discussed with regard to risk factors as 
well as methods to prevent it. 
In the next chapter the research design and methodology will be reviewed. 
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Chapter 3: Research design and methodology 
 
3.1   Introduction 
In this chapter the research methodology will be discussed with regard to the 
problem statement, aim and objectives, demarcation of study field, ethical 
considerations, data collection, data analysis, validity and reliability of the study and 
a summary. 
3.2   Problem statement 
Patients with CRF are considered to be at risk of pulmonary aspiration of gastric 
contents during anaesthesia and consequently the recommendation is to perform a 
RSI on such patients. RSI is not without its risks and may not be necessary. 
3.3   Aim of the study 
The aim of this study was to determine whether patients who are on a chronic 
haemodialysis program have sufficient residual gastric contents after an overnight 
fast, to place them at risk of pulmonary aspiration of gastric contents during 
anaesthesia. 
3.4   Objectives of the study 
Objectives of the study 
The primary objective of this study was to quantify the RGVs, after an overnight fast, 
of patients who are on a haemodialysis program by means of ultrasound assessment 
of the gastric antrum. 
The secondary objectives of this study were to:  
 describe the gastrointestinal symptoms of the patients 
 compare the RGVs in patients with and without gastrointestinal symptoms 
 correlate RGVs with the urea concentrations 
 correlate RGVs with the creatinine concentrations. 
 
3.5   Demarcation of study field 
The study was conducted at a private hospital in Johannesburg. The study was done 
in the renal dialysis unit and the radiology department. The dialysis unit serves 
around 70 patients on chronic haemodialysis with varied aetiologies for their CRF. 
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3.6   Ethical considerations 
Approval to conduct the study was obtained from the Human Research Ethics 
committee (Medical) (Appendix 1) and the Post Graduate Committee (Appendix 2) of 
the University of the Witwatersrand. Approval was also obtained from the Research 
Ethics Committee of the private hospital group (Appendix 3) and verbal consent from 
the head of the renal dialysis unit. The nursing staff were informed of the study. 
The researcher approached the patients, explained the study and invited them to 
take part. Those patients who agreed received a patient information letter (Appendix 
4) and signed a consent form (Appendix 5). 
Anonymity and confidentiality was ensured as there was no identifiable information 
on the data collection forms (Appendix 6) and patients were allocated a study 
number. Patients’ names and corresponding study number were kept on a list kept 
separately from the data. Only the researcher and supervisors had access to the raw 
data. The data will be stored securely for a period of six years following completion 
of the study. 
The study was conducted in accordance with the declaration of Helsinki (65) and the 
South African Good Clinical Practice Guidelines. 
 
3.7   Research methodology 
3.7.1 Research design 
A prospective, cross sectional descriptive research design was used. 
Prospective study: a study in which variables are measured at the time in which the 
study takes place (66). In this study patients were recruited, signed consent, and 
data was collected thereafter. 
Cross-sectional study: A research study that collects data on participants at one 
point in time (66). In this study data was collected on each patient on the day of the 
ultrasound. 
Descriptive study: “Research study in which phenomena are described, or the 
relationship between variables is examined; no attempt is made to determine cause 
and effect relationships.” (66) A descriptive study design best served the purpose of 
this study.  
3.7.2 Study population  
The study population comprised patients who were treated in a private 
haemodialysis unit in a hospital in Johannesburg. 
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3.7.3 Study sample 
Sampling method 
A convenience sample was used in this study due to the nature of the study and in 
order to obtain an adequate sample size. Convenience sampling is a form of non-
random sampling where the most readily accessible individuals are used in obtaining 
an estimate of a particular element of interest (67).  
Sample size  
The sample size was realised by the number of patients that met the criteria for this 
study.  
Inclusion and exclusion criteria 
The following inclusion criteria were used in the study: 
 patients with CRF who were 18 years or older 
 who had been on haemodialysis for at least six months 
 and who consented to take part in the study. 
Patients with the following were excluded from the study: 
 diabetes mellitus 
 a history of previous surgery which could distort the anatomy of the stomach 
and oesophagus 
 a history of hiatus hernia 
 those on medications which may affect gastric emptying specifically 
erythromycin or metoclopramide 
 a BMI > 35 kg/m2 
 patients who were pregnant. 
3.7.4 Data collection 
The data was collected during the period from June 2013 to May 2014. 
A list was composed with all the eligible patients who regularly attended the 
haemodialysis unit. The patients were approached on one of their dialysis days and 
the study was explained to them. An information letter (Appendix 4) was provided, 
detailing the purpose and methods of the study. If they agreed to participate in the 
study they were asked to sign consent (Appendix 5).  
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Once the patients were recruited they were interviewed about gastrointestinal 
symptoms and results were recorded on the data collection sheet (Appendix 6). Urea 
and creatinine concentrations were obtained from their files and written on the data 
collection sheet. The patient was then asked to come in on a morning between 8 and 
9 am before their dialysis session and after an overnight fast for an ultrasound 
examination of their stomach. 
The ultrasounds were performed in the radiology department of the hospital by a 
radiologist experienced in sonography. All patients were fasted as per general 
hospital protocol, i.e. nil per os after going to bed or midnight, whichever was earlier. 
Patients were scanned in the supine position followed by the right lateral decubitus 
position. The transducer was placed in the sagittal plane in the epigastric region. The 
antrum was visualized in the parasagittal plane in the epigastric region using the left 
lobe of the liver, the inferior vena cava and the superior mesenteric vein as 
landmarks. Once these landmarks were identified the transducer was rotated to 
visualize the best view of the antrum. The anterioposterior and craniocaudal 
diameters of the antrum were then marked out from serosa to serosa and care was 
taken to do measurements with the antrum at rest between peristaltic movements. 
CSA of the antrum was then calculated using the formula described by Bolondi (16) 
in which the two maximum perpendicular diameters are used. This formula 
represents the surface area of an ellipse. 
CSA =
AP × CC × π
4
 
Where AP is the anterioposterior diameter and CC is the craniocaudal diameter. 
Once the CSA was known the gastric volumes were calculated using the following 
equation: Volume = 27.0 + 14.6 × Right lateral CSA – 1.28 × age. 
The mathematical model for the above equation was developed by Perlas et al in 
2013 and can be used to estimate gastric volumes of between 0 and 500 mls, in 
non-pregnant adults with a BMI < 40kg/m2 (17). 
Based on the results of the interview on gastrointestinal symptoms, patients were 
grouped as dyspeptic or not. The interview elicited symptoms of heartburn or acid 
reflux, nausea, vomiting, abdominal bloating and early satiety.  
Once the ultrasound examination had been performed the patients returned to the 
dialysis unit where they were provided with a meal. 
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3.8  Data analysis 
Raw data was captured using Excel 2013 (Microsoft USA). Data was analysed using 
StatCalc version 7.3.3, a program by AcaStat software. A Fisher’s exact test was 
performed to check for any association between the presence of gastrointestinal 
symptoms and gastric volumes which were divided into those above 0.4ml/kg and 
those below. Continuous variables such as plasma levels of urea and creatinine and 
gastric volumes were correlated using Pearson correlation coefficient. A statistical 
significant association was taken as p <0.05. 
 
3.9   Validity and reliability of the study 
According to Botma et al (68) validity “indicates whether the conclusions of the study 
are justified based on the design and interpretation” and reliability represents “the 
consistency of the measure achieved”. 
The validity and reliability in this study were ensured by the following: 
 using an appropriate study design 
 using the same ultrasound machine on all the patients 
 the ultrasounds being performed by a single expert radiologist 
 the remaining data was collected by the researcher only ensuring consistency 
 the formula used to calculate gastric volumes was a validated formula 
 all data entry on the excel spreadsheet was double checked. 
 
3.10 Summary 
This chapter provided a discussion of the problem statement, the aim and objectives, 
demarcation of the study field, ethical considerations, research design and 
methodology, data analysis and validity and reliability.  
In the next chapter the results and a discussion thereof will be presented. 
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Chapter 4: Results and discussion  
 
4.1   Introduction  
This chapter describes the results of the study according to the objectives, followed 
by a discussion. 
The primary objective of this study was to quantify the RGVs, after an overnight fast, 
of patients who are on a haemodialysis program by means of ultrasound assessment 
of the gastric antrum. 
The secondary objectives of this study were to:  
 describe the gastrointestinal symptoms of the patients 
 compare the RGVs in patients with and without gastrointestinal symptoms 
 correlate RGVs with the urea concentrations 
 correlate RGVs with the creatinine concentrations. 
 
4.2   Results 
Data was collected during the period from June 2013 to May 2014. The dialysis unit 
treats around 70 patients at any given time. Twenty patients met the inclusion criteria 
and consented to participate in the study. The majority of the patients in the unit 
were diabetic (around 30 patients) and the balance refused to consent to participate 
in the study. Reported results have been rounded off to two decimal places. 
4.2.1 Patient demographics 
Demographics of the 20 patients included in the study are shown in Table 4.1. 
Table 4.1 Patient demographics 
Demographic  Mean (SD) Min Max 
Age (years) 48  (19) 20 80 
Height (cm) 167  (10) 150 178 
Weight (kg) 72  (14) 43 103 
Body Mass Index 
(kg/cm2) 
26  (4) 19 31 
Urea concentration 
(mmol/L) 
23  (6) 14 38 
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Creatinine 
concentration (µmol/L) 
858  (256) 421 1277 
 
 
4.2.2 Gastric volumes  
To aid understanding of the results to follow, a few definitions used in this study have 
been repeated. 
Qualitative assessment: The sonographic appearance of the gastric antrum made 
using a three point grading system (22).  
 Grade 0: The antrum is assumed to be empty. The anterior and posterior 
walls are adjacent to one another and no fluid can be visualised in either the 
supine or the lateral decubitus position. 
 Grade 1: The antrum is assumed to contain a volume of fluid within the “safe” 
range (less than 0.8ml/kg). The fluid can only be visualized in the lateral 
decubitus position and not in the supine position. 
 Grade 2: These patients may be considered at risk of perioperative 
pulmonary aspiration (volume greater than 0.8ml/kg). The gastric antrum is 
distended in both the supine and the lateral positions. If the distended lumen 
is hypoechoic it contains fluid. If it has a frosted glass appearance it contains 
solid contents. 
 
Empty Stomach: 
 volume of gastric contents not exceeding 0.4 ml/kg body weight or 
 Grade 0 appearance on ultrasound 
Not at increased risk of PPA: 
 volume of gastric contents greater than 0.4 ml/kg but less than 0.8 ml/kg and 
 Grade 1 appearance on ultrasound. 
At risk of PPA: 
 gastric contents which exceed 0.8 ml/kg or 
 Grade 2 appearance on ultrasound 
Once the CSA was known the gastric volumes were calculated using the following 
equation: Volume = 27.0 + 14.6 × Right lateral CSA – 1.28 × age. 
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The primary objective of this study was to quantify the RGVs, after an 
overnight fast, of patients who are on a haemodialysis program by means of 
ultrasound assessment of the gastric antrum. 
The RGVs will be quantified by: 
1. Calculating the total volume of the stomach in mls. 
2. Calculating the relative volume of the stomach in ml/kg. 
3. Qualitative assessment using the grading system. 
The calculated gastric volumes are presented in Table 4.2 
Table 4.2 Calculated gastric volumes  
 
The total gastric volumes for the 20 participants are shown in Figure 4.1 
 
Figure 4.1 Total gastric volumes 
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Confidence 
interval 
Right lateral CSA  of the 
gastric antrum (cm2) 
4.04 (1.25) 2.23 6.91 3.45 – 4.63 
Total volume (ml) 25.91  
(13.78) 
0 52.65 19.46 – 32.36 
Relative volume (ml/kg) 0.37  (0.21) 0 0.88 0.28 – 0.47 
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The relative gastric volumes of the 20 patients are shown in Figure 4.2 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Relative gastric volumes 
In order to further group the patient risk of PPA, relative gastric volumes were 
divided into 
 those less than 0.4 ml/kg 
 those between 0.4 and 0.8 ml/kg 
 those greater than 0.8 ml/kg 
Ten patients had volumes less than 0.4 ml/kg. Nine patients had volumes greater 
than 0.4ml/kg and less than 0.8 ml/kg. One patient had a volume greater than 
0.8ml/kg 
Qualitative assessment of gastric volumes: 
Three of the patients (15%) were assessed as Grade 1. The other 17 patients (85%) 
were assessed as Grade 0. None of the patients were assessed as Grade 2. 
The calculated gastric volumes of the three patients assessed as Grade 1 were 0.60 
ml/kg; 0.56 ml/kg and 0.27 ml/kg.  
The one patient that had a calculated gastric volume of 0.88 ml/kg was graded 
qualitatively as grade 0.  
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Once the volumes of the gastric antrums were known and the appearance 
graded, patients are grouped into one of the three categories: 
 Empty stomach 
 Not at increased risk of PPA 
 At risk of PPA 
Seventeen patients (85%) were grouped as empty stomachs. Three patients (15%) 
were grouped as not at risk of PPA. No patient was at risk of PPA. 
 
4.2.3 Gastrointestinal symptoms 
The first secondary objective was to describe the gastrointestinal symptoms 
of the patients. 
A history of gastrointestinal symptoms was obtained as would be done on a routine 
anaesthetic preoperative interview. Patients were asked about heartburn, nausea 
and vomiting, abdominal bloating and early satiety. Twelve patients (60%) were 
found to have gastrointestinal symptoms.  
Heartburn  
Two (10%) patients experienced frequent episodes of heartburn. Four (20%) patients 
experienced occasional mild discomfort. The other fourteen patients (70%) had no 
symptoms. See Figure 4.3. 
Nausea and vomiting 
Two (10%) patients experienced frequent nausea with vomiting. Five patients (25%) 
had occasional nausea. Thirteen patients (65%) had no symptoms. See Figure 4.3. 
Abdominal Bloating 
Two patients (10%) experienced frequent bloating. Four patients (20%) had 
occasional bloating. Fourteen patients (70%) did not experience bloating. See Figure 
4.3. 
Early Satiety 
One patient (5%) frequently had early satiety. Four patients (20%) sometimes had 
early satiety. Fifteen (75%) never experienced this. See figure 4.3. 
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Figure 4.3 Frequency of gastrointestinal symptoms 
 
The second secondary objective was to compare the RGVs in patients with 
and without gastrointestinal symptoms. 
Gastric volumes were divided up into those greater than 0.4ml/kg and those less 
than 0.4ml/kg.  
A Fisher’s exact test was then performed to check for any association between 
gastrointestinal symptoms and gastric volumes. The two sided p value was 0.65 
which is not considered significant. See Table 4.4 
Table 4.3 Fisher’s exact test 
 Less than 0.4 
ml/kg 
More than 
0.4ml/kg 
Total  
Gastrointestinal 
symptoms present 
7 (35%) 5 (25%) 12 (60%) 
Gastrointestinal 
symptoms absent 
3 (15%) 5 (25%) 8 (40%) 
Total  10 (50%) 10 (50%) 20 (100%) 
P = 0.65 
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4.2.4 Correlation between RGVs and urea concentrations  
The third secondary objective addressed was the correlation between RGVs 
and the urea concentrations. 
This was done using Pearson Correlation Coefficient. See Figure 4.4 
There was no correlation. (p = 0.43). 
 
Figure 4.4 Correlation between RGVs and urea concentrations 
Pearson Correlation Coefficient (r): 0.19 meaning no correlation was found. 
p = 0.43 which is not significant. 
 
4.2.5 Correlation between RGVs and creatinine concentrations 
The fourth secondary objective was to correlate RGVs with creatinine 
concentrations. 
This was done using Pearson Correlation Coefficient. See Figure 4.5 
There was no correlation. (p = 0.08) 
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Figure 4.5 Correlation between RGVs and creatinine concentrations 
Pearson Correlation Coefficient (r): 0.40 showing a weak positive relationship 
p = 0.08 which is not significant 
 
4.3   Discussion 
In this study patients with CRF receiving chronic haemodialysis were assessed for 
the presence of gastric content after an overnight fast. A visual assessment of the 
sonographic appearance of the gastric contents was performed and a grade was 
given. The volume of gastric content was calculated and the risk of PPA was 
evaluated. 
All 20 patients included in the study were not considered to be at an increased risk of 
PPA. These finding are consistent with those of previous studies in which patients 
receiving haemodialysis were shown to have normal gastric emptying. (9, 20)  
Patients with CRF, not on dialysis, have been found to have delayed gastric 
emptying and decreased gastric motility (52). There is a study showing that patients 
not yet receiving haemodialysis have delayed gastric emptying compared with those 
who were receiving haemodialysis (8). An improvement in gastric emptying and 
gastric motility has been found in patients being dialysed (55). There is however 
conflicting evidence which suggests that both subgroups have delayed gastric 
emptying (21). One study included 56 patients all receiving haemodialysis and 
compared them to a healthy control group; they found gastric emptying to be 
significantly delayed in the CRF group (48). 
Delays in gastric emptying associated with CRF are believed to be due to a multitude 
of aetiologies. (40, 41) Through the correction of some of the electrolyte 
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abnormalities and removal of uraemic toxins, haemodialysis may improve gastric 
emptying and motility. Haemodialysis does not however appear to remove 
gastrointestinal hormones involved in gastric emptying (44). 
The patients in this study were all fasted for a minimum of eight hours prior to 
assessment of their gastric contents. In the literature reviewed, gastric emptying 
times were assessed and although prolonged in some studies the actual fasting 
volume does not seem to have been evaluated (8, 9, 21, 48). 
In our study, when the appearance of the gastric antrum was assessed by the 
radiologist, seventeen patients were considered Grade 0, three were Grade 1 and 
none of the patients were considered as Grade 2. Thus no patients were at risk of 
PPA. This is in conflict with current teaching. (5) 
The gastric volumes were calculated based on the equation validated by Perlas et al 
(17). Ten patients (50%) had gastric volumes less than 0.4ml/kg, nine patients (45%) 
had gastric volumes of between 0.4 ml/kg and 0.8 ml/kg, one patient (5%) had a 
gastric volume of greater than 0.8 ml/kg. The patient with the gastric volume of 0.88 
ml/kg (52 mls) was 20 years old and the equation which calculated the gastric 
volume has age as a co-variant, calculating higher gastric volumes in younger 
patients. A patient with the same CSA of the gastric antrum who was 70 years old 
would have had a calculated volume of less than 10 mls. (30) In this particular case 
the radiologist graded the gastric antrum as Grade 0, having visualized no fluid 
within the stomach. This discrepancy may be due to small amounts of air in the 
stomach or a thicker antral wall. The diameters of the gastric antrum are measured 
from serosa to serosa, therefore an antrum that is totally empty is expected to have a 
CSA that is more than 0, corresponding to the thickness of the gastric wall (usually in 
the order of 2–5 cm2). (17) 
Patients were questioned about specific gastrointestinal symptoms and the 
frequency thereof. In total twelve patients reported experiencing at least one of the 
symptoms asked about. There was no association between gastric volumes and 
gastrointestinal symptoms. This is consistent with the findings of Strid (10). However 
there are conflicting finding in Van Vlems’ study which reflected significant delays in 
gastric emptying in patients with dyspeptic symptoms. (7) We were not however 
measuring the gastric emptying times in our study, so it is possible that while there 
may be delays in gastric emptying, once fasted, the gastric volumes of the patients in 
our study were not high enough to place patients at risk of PPA. An overnight fast 
may provide sufficient time for the stomach to empty despite the delays in gastric 
emptying described in the literature. (21, 48) Since, in the fasted state, none of the 
patients had gastric volumes that were considered raised it was difficult to say 
whether raised gastric volumes were associated with dyspeptic symptoms. 
The final objectives in our study were to correlate the RGVs with both the urea and 
the creatinine levels. The mean urea concentration was 23 mmol/l with a range from 
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14 to 38 mmol/l. No correlation was found between RGVs and urea concentrations. 
Similarly no correlation was found between RGVs and creatinine concentrations. 
When the literature was reviewed no reference to correlations between RGVs and 
urea or creatinine levels could be identified. 
                               
4.4   Summary 
In this chapter the results were presented and discussed according to the objectives 
of this study.  
The final chapter will provide a summary of the study, including its limitations 
recommendations and conclusions. 
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Chapter 5: Summary, limitations, recommendations and 
conclusion 
 
5.1   Introduction 
In this chapter a summary of the study will be provided followed by a discussion of 
the limitations of the study. The clinical recommendation and recommendations for 
future research that became apparent during the course of this study will be 
discussed. Lastly the conclusion of the study will be presented. 
 
5.2   Summary of the study 
Aim of the study 
The aim of this study was to determine whether patients who are on a chronic 
haemodialysis program have sufficient residual gastric contents after an overnight 
fast, to place them at risk of pulmonary aspiration of gastric contents during 
anaesthesia. 
Objectives of the study 
The primary objective of this study was to quantify the RGVs, after an overnight fast, 
of patients who are on a haemodialysis program by means of ultrasound assessment 
of the gastric antrum. 
The secondary objectives of this study were to:  
 describe the gastrointestinal symptoms of the patients 
 compare the RGVs in patients with and without gastrointestinal symptoms 
 correlate RGVs with the urea concentrations 
 correlate RGVs with the creatinine concentrations. 
 
Methodology of the study 
All patients who met the inclusion criteria in the dialysis unit were identified. Once 
they had consented to participate in the study the researcher asked about 
gastrointestinal symptoms and blood results for urea and creatinine concentrations 
were taken from their files. 
An ultrasound was scheduled for a morning on which the patient was due to come in 
for a morning dialysis session and the patient was asked to take nothing by mouth 
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from bedtime or midnight the night before. The appearance of the stomach and the 
contents were graded by the radiologist and the diameters of the gastric antrum were 
then measured so that the CSA could be calculated. 
Once the CSA was known the gastric volume was calculated using a validated 
equation. These volumes where then divided by the patients weight to get the 
relative gastric volume in ml/kg. The risk of PPA was then assessed according to the 
graded appearance of the stomach as well as calculated gastric volumes. A cut off 
value of 0.8 ml/kg was used as a relative gastric volume that would place the patient 
at increased risk of perioperative pulmonary aspiration. Any patient with a gastric 
antrum found to be distended in both the supine and lateral positions was assessed 
as Grade 2 placing them at increased risk of PPA. All data was then entered onto a 
data collection sheet.   
A Fisher’s exact test was performed to check for any possible associations between 
gastrointestinal symptoms and RGVs. A Pearson correlation was used to correlate 
both urea and creatinine levels with RGVs.   
 
Main findings of the study 
In our study none of the patients were assessed as being at risk of PPA. The 
assessment of the gastric antrum by the radiologist in which the appearance of the 
stomach was graded, found none of the patients to have a significant amount of fluid 
or any solid contents. 85% of the patients had completely empty stomachs and 15% 
had a small amount of fluid considered to be within the normal range. In all patients 
the gastric antrum was adequately visualised.  
In the three patients where some fluid was visualized, the calculated gastric volumes 
all fell below the threshold of 0.8 ml/kg considered to place them at risk of PPA.  
Gastrointestinal symptoms were found in in 60% of patients. There was no 
association between gastrointestinal symptoms and RGVs. 
There was no correlation between either urea or creatinine concentrations and 
RGVs. 
 
5.3   Limitations of the study 
The generalisability of this study should be viewed with certain limitations in mind.  
This study was done contextually in a single dialysis unit at a private hospital and the 
results may not be generalised to other hospitals. 
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This was a pilot study with a small number of patients, and although it provides us 
with valuable insight it may be underpowered. The secondary objectives should be 
interpreted with caution. 
Due to the fact that 85% of the patients had empty stomachs, the comparisons to 
gastrointestinal symptoms and correlations to urea and creatinine concentrations 
should also be interpreted with caution. 
Although RGVs were assessed, the pH of the gastric contents is considered an 
important contributing factor to morbidity following an episode of PPA and this was 
not tested due to the invasive nature of the test. 
Fasting periods were not uniform amongst patients with a minimum of eight hours 
but some patients may have been fasted for up to 14 hours depending on when they 
went to bed. Exact fasting times for individual patients were not recorded. 
Assessment of autonomic function is an important factor related to aspiration risk in 
patients with CRF. Autonomic dysfunction was not assessed in the patients in our 
study. 
There is controversy as to the value for residual gastric volumes that would place a 
patient at increased risk for PPA, with values of 0.8ml/kg quoted in the literature (61) 
as well as values of 1.5ml/kg (29).  The threshold value for aspiration risk used in our 
study was chosen as 0.8ml/kg and not 1.5ml/kg due to the fact all patients our study 
had a calculated value for RGV’s that was less than 1.5ml/kg. 
 
5.4   Recommendations from this study 
5.4.1 Recommendations for clinical practice 
Anaesthetists should not make assumptions about the risk of PPA in patients with 
CRF. A patient with CRF on chronic haemodialysis presenting for anaesthesia 
following a fast of greater than 8 hours does not necessarily have RGVs that would 
place them at risk of PPA. There are other risk factors for PPA and each patient 
should be assessed individually. Although the airway should still be protected during 
most surgical procedures RSI may not be necessary. When in doubt about the risk of 
PPA in a particular patient bedside ultrasound by an experienced operator may 
provide a quick, easy and reliable assessment of the gastric contents.  
The presence of gastrointestinal symptoms does not correspond to a raised RGV 
after an overnight fast. The urea and creatinine levels also show no correlation to 
RGVs. 
The use of ultrasound to assess the gastric contents and therefore the risk of PPA 
should be considered in the perioperative setting, particularly in the emergency 
situation where fasting times have not been adhered to, as well as in patients 
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considered to be at high risk of PPA. Ultrasound evaluation of gastric contents may 
lead to prevention of unnecessary delays and cancellations of cases where there is 
doubt about fasting status of a patient. Where a full stomach is found preoperatively 
the risk/benefit of preceding can be assessed and methods of reducing the risk of 
PPA can be put into place. Training in the use of ultrasound to assess the gastric 
antrum by anaesthesiologists would be invaluable. 
 
 
5.4.2 Recommendations for further research 
A similar study in patients not yet receiving haemodialysis in order to assess whether 
the RGVs are greater than those on our study. 
Evaluation of gastric contents using bedside ultrasound prior to induction of 
anaesthesia in the elective and emergency situation in order to assess risk of PPA in 
all patients. 
Since this is a pilot study, a larger sample size would yield more powerful results, 
especially with regard to the secondary objectives. A future well designed multicentre 
study investigating the same parameters as our study in patients with ESRD. This 
study would need to be well powered and would need collaboration from different 
centers nationally and internationally. 
A similar study which included the assessment of autonomic function would be 
valuable. 
 
5.5   Conclusion 
In this study patients with CRF on a haemodialysis program were not found to have 
RGVs, once fasted, that would place them at increased risk of PPA. 
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Appendix 4: Patient information letter 
Hello. 
My name is Dr Natalie Burger. I am an anaesthetic doctor currently training at the Charlotte Maxeke 
Johannesburg Academic Hospital. 
 
I would like to invite you to be part of a study that I will be conducting over the next few months at the 
xxx hospital haemodialysis unit.  
 
The reason for the study is that many patients who have got chronic renal failure experience some 
stomach symptoms such as nausea or heartburn. One of the possible reasons for this is that the 
stomach does not empty as quickly as it should, after eating a meal. 
 
I am interested in whether the stomach is empty in the morning after around ten hours without food. 
As an anaesthetic doctor this is an important question. Patients who come to theatre for an operation 
usually are told not to eat anything after they go to bed at night so that their stomachs are empty on 
the morning of their operation. If the stomach is not empty the patient might vomit during or after the 
anaesthetic, which could be dangerous for the patient. If the anaesthetic doctor knows that the 
stomach is full they will change the way that the put the patient to sleep for the operation. 
 
I would like to know if after a night without food (an overnight fast) there is anything left in your 
stomach. 
 
If you would like to be part of this study, we will arrange for a radiologist to do an ultrasound on your 
stomach when you come in for one of your dialysis sessions.  This will be free of charge. I will ask you 
please not to have anything to eat or drink in the morning before you come to the hospital so that the 
results are accurate. After the ultrasound you will be provided with a meal in the dialysis unit. 
 
The ultrasound will take place in the radiology department before your dialysis session. It involves 
putting some special jelly on your abdomen and then the radiologist will put a probe on your abdomen 
which will show a picture of your stomach. The ultrasound should not take more than ten minutes and 
is completely safe. 
 
I will also perform ask you a few questions to find out if you experience any nausea, heartburn or 
bloating of the stomach. 
 
Lastly I would ask your permission to look at your most recent kidney function blood tests, which 
should be on record at the hospital. 
 
All information gathered during the study will be kept in a safe place and only the people working on 
the research will have access to it. Your name will not appear anywhere. 
If you would like to be part of my study I will ask you to sign a consent form. You may withdraw at any 
point if you wish.  
If you have any questions please contact myself or Prof Cleaton Jones. 
My cell number is 084 226 3334 and you can contact Prof Cleaton-Jones on 011 717 2301 
Prof Cleaton- Jones  is Chairperson of the Wits university Human research ethics committee. 
 
Thank you for taking the time to hear about my study. 
Dr Natalie Burger 
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Appendix 5: Consent form 
Informed consent 
 
I,__________________________________________, agree to participate in the 
study that Dr Burger has explained to me. 
Dr Burger has provided me with an information sheet, detailing the purpose of the 
study and how the study will be performed. 
I understand that I will be asked to fast overnight.  
I understand that I will have an ultrasound of my stomach. 
I understand that Dr Burger will ask me some questions and examine me clinically. 
I give Dr Burger permission to take blood results from my file. 
I understand that I may withdraw from the study at any point and I have a contact 
number for Dr Burger. 
 
 
 
 ____________________________________ 
Participant Signature                                                     Date 
 
 ____________________________________ 
Researcher Signature                                                     Date 
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Appendix 6: Data collection Sheet 
Data collection sheet 
1. Patient Information 
 
Patient study Number 
 
 
Age 
 
 
Weight 
 
 
Height 
 
 
2.  Interview on Gastrointestinal symptoms 
2.1 Heartburn or acid reflux 
 
Heartburn occurs when the lower oesophageal sphincter (the muscular ring that acts as a valve 
between the stomach and the oesophagus) relaxes and allows stomach contents and acid to 
flow back from the stomach into the oesophagus. 
 
This may be felt as a burning sensation in the chest or the upper abdomen. The burning 
sometimes radiated to the back.  If the acid reaches the mouth it may taste sour or burn the 
throat. 
 
0 Never experience Heartburn 
1 Occasional mild discomfort, relieved by over the counter medications such as Rennies 
or other antacids. Occurs less than once a week. 
2 Frequent episodes, very uncomfortable. More than once a week. Only some relief from 
over the counter medications. May be on prescription medications for high acid levels 
(reflux).  
 
2.2  Nausea and vomiting  
Nausea is the feeling that you want to vomit. 
0 No symptoms of nausea  
1 Occasional nausea, generally does not lead to vomiting 
2 Frequent nausea. Sometimes vomiting  
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2.3  Abdominal Bloating 
Abdominal bloating may occur normally after a large meal. The abdomen feels full and tense and 
may be distended and painful. 
0 Never feel bloated 
1 Occasional bloating, less than once a week 
2 Frequent bloating, more than once a week 
 
2.4  Early Satiety 
Satiety is the feeling of being fed or gratified to or beyond the point of capacity (overfull). 
During a meal, as the food reaches the stomach, there is a feeling of fullness in the stomach. 
The question here is does that feeling comes earlier than it should. Does this feeling of fullness 
prevent you from completing your meal? 
0 Never 
1 Sometimes 
2 Always 
 
3. Blood results 
 
 
4. Ultrasound Findings 
4.1 Qualitative findings 
Gastric antrum 
Supine 
Grade 0 Grade 1 Grade 2 
Gastric antrum 
lateral 
Grade 0 Grade 1 Grade 2 
 
       4.2 Quantitative findings 
Gastric antrum 
supine 
AP diameter____mm CC diameter____mm CSA__________cm2 
Gastric antrum 
lateral 
AP diameter____mm CC diameter____mm CSA__________cm2 
 
     4.3 Estimated gastric volume 
Urea  
Creatinine  
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Total volume____________ml 
Relative volume_________ml/kg 
Risk stomach Yes No 
 
 
